146 related articles for article (PubMed ID: 9438929)
1. PET versus SPECT for determining myocardial tissue viability using fluorine-18-fluorodeoxyglucose.
Schraml FV; Driver DR; Randolph T; Silverman ED
J Nucl Med Technol; 1997 Dec; 25(4):272-4. PubMed ID: 9438929
[TBL] [Abstract][Full Text] [Related]
2. Fluorodeoxyglucose imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging?
Bax JJ; Wijns W
J Nucl Med; 1999 Nov; 40(11):1893-5. PubMed ID: 10565786
[No Abstract] [Full Text] [Related]
3. Fluorine-18-fluorodeoxyglucose cardiac imaging using a modified scintillation camera.
Sandler MP; Bax JJ; Patton JA; Visser FC; Martin WH; Wijns W
J Nucl Med; 1998 Dec; 39(12):2035-43. PubMed ID: 9867138
[TBL] [Abstract][Full Text] [Related]
4. Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET.
Chen EQ; MacIntyre WJ; Go RT; Brunken RC; Saha GB; Wong CY; Neumann DR; Cook SA; Khandekar SP
J Nucl Med; 1997 Apr; 38(4):582-6. PubMed ID: 9098206
[TBL] [Abstract][Full Text] [Related]
5. Validity of 18F-fluorodeoxyglucose imaging with a dual-head coincidence gamma camera for detection of myocardial viability.
Hasegawa S; Uehara T; Yamaguchi H; Fujino K; Kusuoka H; Hori M; Nishimura T
J Nucl Med; 1999 Nov; 40(11):1884-92. PubMed ID: 10565785
[TBL] [Abstract][Full Text] [Related]
6. Myocardial viability assessment with FDG imaging: comparison of PET, SPECT, and gamma-camera coincidence detection.
Kerrou K; Toussaint JF; Froissart M; Talbot JN
J Nucl Med; 2000 Dec; 41(12):2099. PubMed ID: 11138698
[No Abstract] [Full Text] [Related]
7. Value and limitation of myocardial fluorodeoxyglucose single photon emission computed tomography using ultra-high energy collimators for assessing myocardial viability.
Mabuchi M; Kubo N; Morita K; Noriyasu K; Itoh Y; Katoh C; Kuge Y; Tamaki N
Nucl Med Commun; 2002 Sep; 23(9):879-85. PubMed ID: 12195093
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the clinical value of combination of 99mTc-MIBI myocardial SPECT and 18F-FDG PET in assessing myocardial viability.
Zhang X; Liu X; Shi R; Wu Q; Gao R; Liu Y; Hu S; Guo S; Xie F; Li Y
Radiat Med; 1999; 17(3):205-10. PubMed ID: 10440109
[TBL] [Abstract][Full Text] [Related]
9. F-18 fluoro deoxyglucose SPECT for assessment of myocardial viability.
Fitzgerald J; Parker JA; Danias PG
J Nucl Cardiol; 2000; 7(4):382-7. PubMed ID: 10958281
[TBL] [Abstract][Full Text] [Related]
10. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability.
Burt RW; Perkins OW; Oppenheim BE; Schauwecker DS; Stein L; Wellman HN; Witt RM
J Nucl Med; 1995 Feb; 36(2):176-9. PubMed ID: 7830109
[TBL] [Abstract][Full Text] [Related]
11. Technology for FDG SPECT with a relatively inexpensive gamma camera. Work in progress.
Drane WE; Abbott FD; Nicole MW; Mastin ST; Kuperus JH
Radiology; 1994 May; 191(2):461-5. PubMed ID: 8153322
[TBL] [Abstract][Full Text] [Related]
12. [Tumor diagnosis using 18F-FDG SPECT].
Sugiyama S; Suzuki Y; Matsuzaki H; Tomiyoshi K; Endo K
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Aug; 56(9):679-80. PubMed ID: 8831228
[TBL] [Abstract][Full Text] [Related]
13. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium.
Bax JJ; Visser FC; Blanksma PK; Veening MA; Tan ES; Willemsen TM; van Lingen A; Teule GJ; Vaalburg W; Lie KI; Visser CA
J Nucl Med; 1996 Oct; 37(10):1631-6. PubMed ID: 8862297
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
[TBL] [Abstract][Full Text] [Related]
15. 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications.
Bax JJ; Patton JA; Poldermans D; Elhendy A; Sandler MP
Semin Nucl Med; 2000 Oct; 30(4):281-98. PubMed ID: 11105929
[TBL] [Abstract][Full Text] [Related]
16. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.
Ghesani M; Depuey EG; Rozanski A
Echocardiography; 2005 Feb; 22(2):165-77. PubMed ID: 15693785
[TBL] [Abstract][Full Text] [Related]
17. Assessment of myocardial viability with a positron coincidence gamma camera using fluorodeoxyglucose in comparison with dedicated PET.
Tian M; Koyama K; Zhang H; Oriuchi N; Higuchi T; Endo K
Nucl Med Commun; 2003 Apr; 24(4):367-74. PubMed ID: 12673164
[TBL] [Abstract][Full Text] [Related]
18. Metabolic imaging using F18-fluorodeoxyglucose to assess myocardial viability.
Bax JJ; Visser FC; van Lingen A; Cornel JH; Fioretti PM; van der Wall EE
Int J Card Imaging; 1997 Apr; 13(2):145-55; discussion 157-60. PubMed ID: 9110194
[TBL] [Abstract][Full Text] [Related]
19. FDG-SPECT: correlation with FDG-PET.
Martin WH; Delbeke D; Patton JA; Hendrix B; Weinfeld Z; Ohana I; Kessler RM; Sandler MP
J Nucl Med; 1995 Jun; 36(6):988-95. PubMed ID: 7769457
[TBL] [Abstract][Full Text] [Related]
20. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.
vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P
J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
